- Home
- PRLD vs GUTS Comparison
PRLD vs GUTS Comparison
Compare PRLD & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- GUTS
- Stock Information
- Founded
- PRLD 2016
- GUTS 2010
- Country
- PRLD United States
- GUTS United States
- Employees
- PRLD N/A
- GUTS N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- GUTS
- Sector
- PRLD Health Care
- GUTS
- Exchange
- PRLD Nasdaq
- GUTS NYSE
- Market Cap
- PRLD 50.1M
- GUTS 58.8M
- IPO Year
- PRLD 2020
- GUTS 2024
- Fundamental
- Price
- PRLD $0.78
- GUTS $1.62
- Analyst Decision
- PRLD Strong Buy
- GUTS Buy
- Analyst Count
- PRLD 2
- GUTS 1
- Target Price
- PRLD $4.50
- GUTS $10.00
- AVG Volume (30 Days)
- PRLD 110.2K
- GUTS 273.3K
- Earning Date
- PRLD 05-06-2025
- GUTS 05-13-2025
- Dividend Yield
- PRLD N/A
- GUTS N/A
- EPS Growth
- PRLD N/A
- GUTS N/A
- EPS
- PRLD N/A
- GUTS N/A
- Revenue
- PRLD $7,000,000.00
- GUTS $93,000.00
- Revenue This Year
- PRLD N/A
- GUTS N/A
- Revenue Next Year
- PRLD N/A
- GUTS N/A
- P/E Ratio
- PRLD N/A
- GUTS N/A
- Revenue Growth
- PRLD N/A
- GUTS N/A
- 52 Week Low
- PRLD $0.61
- GUTS $0.87
- 52 Week High
- PRLD $6.80
- GUTS $7.89
- Technical
- Relative Strength Index (RSI)
- PRLD 46.96
- GUTS 64.21
- Support Level
- PRLD $0.73
- GUTS $1.47
- Resistance Level
- PRLD $1.00
- GUTS $1.80
- Average True Range (ATR)
- PRLD 0.09
- GUTS 0.14
- MACD
- PRLD -0.01
- GUTS 0.04
- Stochastic Oscillator
- PRLD 18.96
- GUTS 70.49
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.